浙江(jiang)尖(jian)峰(feng)藥業有(you)限公(gong)(gong)司(si)成立(li)于1998年12月31日(ri),系(xi)上市公(gong)(gong)司(si)浙江(jiang)尖(jian)峰(feng)集團股份(fen)有(you)限公(gong)(gong)司(si)(股票(piao)代碼:600668)下(xia)屬(shu)的全資子公(gong)(gong)司(si)。
公司下屬全資、控股(gu)和參股(gu)藥品生產企(qi)業6家(jia)(jia)(jia)、藥品經營企(qi)業3家(jia)(jia)(jia)、國家(jia)(jia)(jia)博士(shi)后科研工作站4家(jia)(jia)(jia)、省(sheng)級院士(shi)專(zhuan)家(jia)(jia)(jia)工作站2家(jia)(jia)(jia),擁有國際、國內(nei)藥品發(fa)明專(zhuan)利52項。公司先后被多次評(ping)為(wei)高新技(ji)術(shu)企(qi)業、國家(jia)(jia)(jia)知識產權示(shi)范企(qi)業,浙江省(sheng)創新型(xing)示(shi)范企(qi)業、浙江省(sheng)專(zhuan)利示(shi)范企(qi)業。
公(gong)(gong)(gong)(gong)司本著(zhu)“立尖峰志,做精品藥(yao)(yao)(yao)”的(de)(de)企業(ye)精神,追(zhui)求“科技(ji)造就(jiu)健康(kang)”的(de)(de)經(jing)營(ying)理念,堅持以(yi)(yi)開發(fa)高(gao)技(ji)術含量、高(gao)附加值的(de)(de)化學(xue)原(yuan)料(liao)藥(yao)(yao)(yao)以(yi)(yi)及新型(xing)的(de)(de)化學(xue)藥(yao)(yao)(yao)、中(zhong)成(cheng)藥(yao)(yao)(yao)制劑(ji)為(wei)(wei)新藥(yao)(yao)(yao)研發(fa)方向,以(yi)(yi)項(xiang)目和(he)(he)資金為(wei)(wei)紐帶,實現了高(gao)質量發(fa)展。與德國(guo)研究機構合(he)(he)作,成(cheng)立中(zhong)德合(he)(he)資浙(zhe)江爾嬰(ying)藥(yao)(yao)(yao)品有(you)限公(gong)(gong)(gong)(gong)司,專業(ye)從(cong)事(shi)嬰(ying)幼兒用藥(yao)(yao)(yao)的(de)(de)研發(fa)生產(chan)與經(jing)營(ying);參(can)股北京慧寶(bao)源(yuan)生物技(ji)術股份有(you)限公(gong)(gong)(gong)(gong)司,合(he)(he)作開發(fa)國(guo)家一類抗腫瘤新藥(yao)(yao)(yao),拓展中(zhong)成(cheng)藥(yao)(yao)(yao)市(shi)場(chang);控股上海北卡醫(yi)藥(yao)(yao)(yao)技(ji)術有(you)限公(gong)(gong)(gong)(gong)司,專業(ye)從(cong)事(shi)醫(yi)藥(yao)(yao)(yao)化工中(zhong)間體、醫(yi)藥(yao)(yao)(yao)原(yuan)料(liao)藥(yao)(yao)(yao)的(de)(de)研發(fa)、生產(chan)和(he)(he)經(jing)營(ying),拓展高(gao)端醫(yi)藥(yao)(yao)(yao)原(yuan)料(liao)藥(yao)(yao)(yao)和(he)(he)中(zhong)間體的(de)(de)國(guo)際(ji)市(shi)場(chang)。公(gong)(gong)(gong)(gong)司將堅持科技(ji)創新,以(yi)(yi)技(ji)術和(he)(he)產(chan)品為(wei)(wei)載體,推進產(chan)學(xue)研的(de)(de)融合(he)(he),不斷提(ti)升公(gong)(gong)(gong)(gong)司管理水平和(he)(he)品牌影(ying)響力,走國(guo)際(ji)化發(fa)展道路。